Testing effectiveness (Phase 2)Ended earlyNCT03281083
What this trial is testing
Levothyroxine for Non-Alcoholic Fatty Liver Disease (NAFLD)
Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Duke-NUS Graduate Medical School 29